The Future of Cholesterol Management: Application of PCSK9 Inhibitors in Practice 2018
The Future of Cholesterol Management: Application of PCSK9 Inhibitors in Practice 2018
Sunday, March 18, 2018 | McCormick Place South Room S100 A | Registration/Breakfast: 5:30 - 5:45 am | Program: 5:45 - 7:45 am
This course is a live CME-certified Ancillary Symposium presented at Endocrine Society Annual Meeting (ENDO) 2018, held in Chicago, IL.This educational activity is supported by an independent medical educational grant from Amgen. ENDO 2018 ancillary symposia are developed through the Endocrine Society’s Special Programs Committee (SPC).
CLICK "START" TO COMPLETE PRESURVEY, EVALUATE SESSIONS, CLAIM CME, AND PRINT A CERTIFICATE OF ATTENDANCE OR CERTIFICATE OF PARTICIPATION.
Target Audience
This activity is intended for endocrinologists and endocrine fellows, primary care and internal medicine physicians, cardiologists, physician's assistants, nurse practitioners, and other healthcare professionals caring for patients with lipid disorders including familial hypercholesterolemia.
Learning Objectives
Upon completion of this educational activity, learners will be better able to:
- Discuss the biology and genetic underpinnings of dyslipidemia as it relates to PCSK9 and the LDL receptor
- Assess the value of newer therapies to treat patients with familial hypercholesterolemia and apply treatment
- Evaluate strategies to optimize commonly used lipid-lowering therapies in patients with familial hypercholesterolemia
Additional Information
DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
Robert E. Eckel, MD
The faculty reported the following relevant financial relationship(s) during the content development process for this activity
Anne Carol Goldberg, MD, FACP: Advisory Board Member: Esperion, Sanofi, Regeneron. Grant Recipient: Amarin, Amgen, IONIS/Akcea, Pfizer, Regeneron, Sanofi, The Medicines Company. Editorial Work: Merck. Exam Committee: American Board of Internal Medicine
Henry N. Ginsberg, MD: Advisory Board Member (Self): Amgen Inc, Merck, Sanofi, Regeneron Pharmaceuticals. Advisory Board Member (Spouse): Kowa. Grant Recipient (Self): Amgen Inc, Merck, Sanofi, Sandoz. Research Investigator (Self): Merck, Regeneron Pharmaceuticals.

MAINTENANCE OF CERTIFICATION
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Review your Diplomate ABIM ID Number(s)
In order to earn and report MOC points to the American Board of Internal Medicine (ABIM), you must:
- Provide your board-certification information in your educational profile. Your profile currently contains the following board ID numbers (must be logged in to view):
Your ABIM Number: [current-user:profile-profile:field-number-abim]*
*If your ABIM number is blank or incorrect as shown above, please click the Update Profile button below to add or correct your profile.
Available Credit
- 2.00 ABIM MOC
- 2.00 AMA PRA Category 1 Credits™
- 2.00 CME Certificate of Participation